Skip to content
Skip to search
Skip to footer
- Aadel Chaudhuri, MD, PhD discusses ctDNA liquid biopsy at the Institute of Cancer Research Symposium in Shenzhen, China (Nov 18, 2022)
- Aadel Chaudhuri, MD, PhD discusses ctDNA MRD at the Liquid Biopsy Surveillance & Early Detection Summit (Nov 16, 2022)
- Aadel Chaudhuri, MD, PhD delivers grand rounds at the London Health Centre at Western University as a Visiting Professor in Radiation Oncology (Nov 8, 2022)
- Noah Earland, MSTP student, delivers oral presentation at the ASTRO Annual Meeting (Oct 25, 2022)
- Aadel Chaudhuri, MD, PhD delivers Michael Fry Award Lecture at the Radiation Research Society Conference (Oct 17, 2022)
- Aadel Chaudhuri, MD, PhD selected as a ASTRO 2022 Social Champion (Oct 14, 2022)
- Aadel Chaudhuri, MD, PhD discusses the role of ctDNA in advancing clinical decision-making (Frontline Genomics; Oct 6, 2022)
- Aadel Chaudhuri, MD, PhD delivers ERO-RO Research Seminar at the MD Anderson Cancer Center (Oct 5, 2022)
- Aadel Chaudhuri, MD, PhD delivers grand rounds at the Mayo Clinic as a Visiting Professor in Radiation Oncology (Sep 23, 2022)
- Aadel Chaudhuri, MD, PhD presents at the Tri-Omics Summit (Frontline Genomics; Sep 28, 2022)
- Aadel Chaudhuri, MD, PhD presents at the AAADV Workshop on ctDNA for cancer detection (Sep 15, 2022)
- Aadel Chaudhuri, MD, PhD gives a research seminar at the Fred Hutchinson Cancer Center in Seattle (Sep 13, 2022)
- Researchers take aim at cancer drugs’ toxic side effects (Science; Aug 31, 2022)
- Physician Scientist Aadel Chaudhuri wins the Michael Fry Award (PD Soros News; Aug 17, 2022)
- New Manuscript Shows Changes in ctDNA Reflect Clinical Benefit to Patients (Friends of Cancer Research; Aug 15, 2022)
- Nicholas Semenkovich, MD, PhD wins best poster award at the Cancer Genomics Consortium (Aug 9, 2022)
- Aadel Chaudhuri, MD, PhD presents the North American perspective on ctDNA at the World Conference for Lung Cancer (Aug 6, 2022)
- Erik Storrs presents in a Podium Presentation at the Cancer Genomics Consortium (Aug 2, 2022)
- Aadel Chaudhuri, MD, PhD speaks at Delta Chi National Conference about cancer research (V Foundation; July 28, 2022)
- Aadel Chaudhuri, MD, PhD speaks at the Friends of Cancer Research ctDNA panel (July 20, 2022)
- Paul Jones highlighted in the WashU Cancer Biology Trainee Corner (July 14, 2022)
- Aadel Chaudhuri, MD, PhD speaks at the ASTRO ROCKS session on transitioning from residency to K-funded physician-scientist (July 12, 2022)
- V Scholar Earns Prestigious Honor (V Foundation; July 8, 2022)
- Chaudhuri recognized by Radiation Research Society (WashU News; July 6, 2022)
- Aadel Chaudhuri, MD, PhD wins the Michael Fry Award from the Radiation Research Society (June 23, 2022)
- Paul Jones, PhD student, wins the Young Investigator Award from the Children’s Tumor Foundation (June 2, 2022)
- Aadel Chaudhuri, MD, PhD invited to give Grand Rounds as Visiting Professor at Dartmouth (May 22, 2022)
- Aadel Chaudhuri, MD, PhD speaks at the V Scholar Summit (May 3, 2022)
- Under the Microscope: Healing Cancer while Avoiding Harm (V Foundation; May 2, 2022)
- Aadel Chaudhuri, MD, PhD speaks at the AstraZeneca T2C Lung Cancer Symposium in Singapore (Apr 19, 2022)
- Aadel Chaudhuri, MD, PhD discusses his research at the NIH Liquid Biopsy Scientific Interest Group (Apr 13, 2022)
- Pancreatic cancer research at AACR highlighted by Siteman Cancer Center (Siteman; Apr 12, 2022)
- Our collaborative research spotlighted in Cancer Cell (Cell Press; March 14, 2022)
- Our collaborative research spotlighted in Med (Cell Press; March 11, 2022)
- NCI CCR Milestones 2022 – Deciphering DNA Clues (National Cancer Institute; March 9, 2022)
- Our collaborative research spotlighted in Trends in Cancer (Cell Press; March 8, 2022)
- T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma (Nature Medicine; Jan 13, 2022)
- Aadel Chaudhuri, MD, PhD discusses his career journey (Washington University Physicians; June 10, 2022)
- As liquid biopsy technology improves, cancer research stands to benefit (Nature Portfolio; Nov 10, 2021)
- Aadel Chaudhuri, MD, PhD, on Personalizing Treatment for Oligometastatic Cancer (The ASCO Post; Oct 30, 2021)
- ctDNA MRD as a biomarker for solid tumors (VJ Oncology; October 28, 2021)
- Siteman Cancer Center at ASTRO (Siteman Cancer Center; Oct 26, 2021)
- Liquid Biopsies May Drive Earlier Detection, Treatments (Oncology Times; Oct 20, 2021)
- Fellows in the News (Paul & Daisy Soros Fellowship; Oct 16, 2021)
- Cancers And Sepsis Being Targeted By cfDNA Liquid Biopsies (Diagnostics World; Oct 13, 2021)
- Blood-Based Biopsy for Cancer-Predisposed Patients (the Pathologist; Oct 9, 2021)
- Novel Test Distinguishes Benign from Malignant Lesions in NF1 (Medscape; Sep 6, 2021)
- Blood, urine biopsies could pave way for more personalized cancer therapy (ScienceDaily; Sep 1, 2021)
- PLOS Medicine Author Interview: Aadel Chaudhuri, MD, PhD (PLOS Medicine; Aug 31, 2021)
- Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors (WashU News, Aug 31, 2021)
- In common genetic disorder, blood test reveals when benign tumors turn cancerous (NIH News, Aug 31, 2021)
- Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease (GenomeWeb; Aug 31, 2021)
- Blood Testing Distinguishes Benign Tumors From Precancerous Condition (GenomeWeb; Aug 31, 2021)
- Liquid Biopsies May Aid Diagnosis, Treatment Of Bladder, Nerve Tumors – Washington University School Of Medicine In St. Louis (Pediatric Daily News; Aug 31, 2021)
- Liquid biopsy may help diagnose and treat bladder, neuroma (Florida News Times; Aug 31, 2021)
- Editor’s Choice: PLOS Medicine Special Issue: Early Detection and Minimal Residual Disease (PLOS Medicine; Aug 31, 2021)
- Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors (Siteman News, Aug 31, 2021
- Chaudhuri Lab awarded MIRA R35 ESI award (R01-equivalent of $1.97 million over 5 years to fund their liquid biopsy research (Aug 23, 2021)
- Currently Relegated for Use in Clinical Trials, MRD Is Poised to Expand Further (Targeted Oncology; Aug 16, 2021)
- Dr. Chaudhuri and Dr. Chen speak about their liquid biopsy ventures at the ICTS Precision Medicine Venture Cafe (ICTS; May 20, 2021)
- Collaborative work on liquid biopsy MPNST sarcoma detection vs. its benign precursor published on medRxiv (medRxiv; April 25, 2021)
- Dr. Chaudhuri has been chosen to lead the ctDNA working group within the Solid Tumor Therapeutics Program (STTP) at Siteman Cancer Center (STTP; April 2021)
- Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients (genomeweb; March 28, 2021)
- ctDNA MRD detection and personalized oncogenomic analysis in colorectal cancer (genomeweb Webinar; March 23, 2021)
- Liquid biopsy for colorectal cancer could guide therapy for tumors (EurekAlert; Feb 12, 2021)
- Liquid biopsy for colorectal cancer could guide treatment (Siteman News; Feb 2021)
- Liquid biopsy for colorectal cancer: Blood and urine samples identify disease that lingers after initial therapy (WashU News; Feb 12, 2021)
- Liquid biopsy for colorectal cancer could guide treatment (NewsWise; Feb 12, 2021)
- Dr. Chaudhuri leads team selected to win Wash U Leadership & Entrepreneurship Acceleration Program (Skandalaris Ctr News; Dec 14, 2020)
- Dr. Chaudhuri is a recipient of the V Foundation V Scholar Award (Siteman News; Nov 24, 2020)
- Chaudhuri receives V Scholar Award (WashU Radiation Oncology Departmental News; Nov 19, 2020)
- Dr. Aadel Chaudhuri awarded the V Scholar Award from the V Foundation (WashU News; Nov 19, 2020)
- Dr. Aadel Chaudhuri presents at the European Association for Cancer Research (EACR) Liquid Biopsy Virtual Event (EACR; Nov 19, 2020)
- Cell-Free DNA Analysis Could Aid in Detection, Optimal Management of Resistant Metastatic Prostate Cancer (OncLive News; Aug 18, 2020)
- Conversation with Aadel Chaudhuri MD PhD Part 1 | Part 2 | Part 3 (Cancer Research Foundation; July 22, 2020)
- Blood test for metastatic prostate cancer could suggest better treatment options (Siteman News; June 18, 2020)
- The Chaudhuri lab’s ctDNA analysis and enrollment protocol titled “Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors” is now on ClinicalTrials.gov under ID# NCT04354064 (ClinicalTrials.gov; April 2020)
- Aadel Chaudhuri MD PhD quoted by The Scientist regarding his perspective on conference cancellations in the wake of Coronavirus (The Scientist; March 2020)
- Aadel Chaudhuri MD PhD receives a grant from the Institute of Clinical and Translational Sciences to research urine tumor DNA in bladder cancer (Wash U Radiation Oncology News; Jan 2020)
- Alvin J. Siteman fund grants $600,000 to Aadel Chaudhuri MD PhD, Chris Maher PhD, and Russell Pachynski MD for advanced-stage prostate cancer research (Siteman News; Dec 2019)
- Nadja Pejovic, medical student in Dr. Chaudhuri’s lab, delivers an oral presentation at the Radiation Research Society meeting in the session Imaging and Circulating Biomarkers of Radiation Response (Wash U Rad Onc News; Nov 2020)
- Aadel Chaudhuri MD PhD quoted in Cancer Discovery article on the recent TRACERx papers published in Nature Medicine (Cancer Discovery; Nov 2019)
- Aadel Chaudhuri MD PhD mentioned as part of the team led by Aaron Newman PhD that developed the CIBERSORTx computational tool for high-resolution in silico tissue dissection (Stanford Medicine News; May 2019)
- Aadel Chaudhuri MD PhD awarded a NCI K08 award to study ctDNA as a liver cancer biomarker (Wash U Rad Onc News; March 2019)
- Aadel Chaudhuri MD PhD mentioned as part of the team behind urine DNA test for bladder cancer detection (Stanford Medicine News; Jan 2019)
- Aadel Chaudhuri MD PhD named a 2018 CRF Young Investigator Award winner (Cancer Research Foundation; Dec 2018)
- Aadel Chaudhuri MD PhD interviewed on using liquid biopsies to assess radiotherapy response (Imaging Technology News; Nov 2018)
- Aadel Chaudhuri MD PhD named 2018 awardee of the Pancreatic Cancer Career Enhancement Program (SPORE; July 2018)
- Aadel Chaudhuri MD PhD wins Roentgen Research Award (RSNA; July 2018)
- Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer (Cancer Discovery; Dec 2018)
- Video interview of Aadel Chaudhuri MD PhD and Maximilian Diehn MD PhD: ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation Therapy (cancerNetwork; Nov 14, 2017)
- Lung Cancer Recurrence, Predictable at Last? (Inside Science; Nov 8, 2017)
- Blood Test for Tumor Cell DNA May Help Predict Localized NSCLC (Oncology Times; Nov 2017)
- ASTRO presents award for top resident conference abstract to Aadel Chaudhuri MD PhD (HemOnc Today; Oct 15, 2017)
- ASTRO 2017: Predicting Response to Lung Cancer Treatment With Circulating Tumor DNA Analysis (JNCCN360; Oct 2, 2017)
- Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (Imaging Technology News; Sep 29, 2017)
- Predicting lung cancer recurrence by analyzing circulating tumor DNA (Scope, Stanford Medicine’s blog; Sep 28, 2017)
- Liquid Biopsy May Show Poor Prognosis in Early NSCLC (Medpage Today; Sep 27, 2017)
- Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment (The ASCO Post; Sep 26, 2017)
- Biomarker blood test predicts survival following localized lung cancer treatment (Markets Insider; Sep 24, 2017)
- Biomarker blood test predicts survival following localized lung cancer treatment (ASTRO; Sep 23, 2017)
- ASTRO honors 43 researchers including Aadel Chaudhuri MD PhD who won the Clinical/Basic Science Research Award for top resident abstract at the 2017 Annual Meeting (ASTRO; Aug 30, 2017)
- Does Plasma-Based Molecular Testing Have a Role in the Routine Care of Lung Cancer? (Clinical Advances in Hematology & Oncology; Aug 2017)
- 2017 Conquer Cancer Foundation Grants and Awards Ceremony honors Aadel Chaudhuri MD PhD for winning Young Investigator Award (ASCO; June 4, 2017)
- Aadel Chaudhuri MD PhD wins RSNA Research Resident/Fellow Grant (RSNA; March 2017)